Policy | February 02, 2024
Industry’s reaction to Union Budget 2024-25
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Tritan Renew, which is made with 50% certified recycled content derived from hard-to-recycle waste, performs like virgin-quality material
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Medway setup a state-of-the-art Heart Institute in Chennai
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Subscribe To Our Newsletter & Stay Updated
